The interaction between CD300a and phosphatidylserine inhibits tumor cell killing by NK cells

European Journal of Immunology

Volumn 43, Issue 8, 2013, Pages 2151-2161

  Lankry, Dikla ^a   Rovis, Tihana Lenac ^b   Jonjic, Stipan ^b   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY   (Israel)

^b UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

CD300; Ligand; Phosphtidylserine; Tumor cell

Indexed keywords

ANTIGEN; CD300A ANTIGEN; CD300C ANTIGEN; LIGAND; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD300A; PHOSPHATIDYLSERINE; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CELL KILLING; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; TUMOR CELL; TUMOR IMMUNITY;

CD300; LIGAND; PHOSPHTIDYLSERINE; TUMOR CELL;

ANTIGENS, CD; ANTIGENS, SURFACE; APOPTOSIS; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; HYBRIDOMAS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; PHAGOCYTOSIS; PHOSPHATIDYLSERINES; RECEPTORS, IMMUNOLOGIC; TUMOR ESCAPE;

EID: 84881489628     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343433     Document Type: Article

References (52)

1. , N. D., Vosshenrich, C. A. and Di Santo, J. P., Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat. Rev. Immunol. 2007. 7: 703-714.
2. Pyzik, M. and Vidal, S. M., Natural killer cells: NK cells stroll down the memory lane. Immunol. Cell Biol. 2009. 87: 261-263.
3. Biron, C. A., Expansion, maintenance, and memory in NK and T cells during viral infections: responding to pressures for defense and regulation. PLoS Pathog. 2010. 6: e1000816.
4. Sun, J. C. and Lanier, L. L., Versatility in NK cell memory. Immunol. Cell Biol. 2011. 89: 327-329.
5. Sun, J. C., Lopez-Verges, S., Kim, C. C., DeRisi, J. L. and Lanier, L. L., NK cells and immune "memory". J. Immunol. 2011. 186: 1891-1897.
6. Zimmer, J., Natural killer cells: at the forefront of modern immunology. Springer, 2009.
7. Biassoni, R., Cantoni, C., Pende, D., Sivori, S., Parolini, S., Vitale, M., Bottino, C. et al., Human natural killer cell receptors and co-receptors. Immunol. Rev. 2001. 181: 203-214.
8. Caligiuri, M. A., Human natural killer cells. Blood 2008. 112: 461-469.
9. Lebbink, R. J. and Meyaard, L., Non-MHC ligands for inhibitory immune receptors: novel insights and implications for immune regulation. Mol. Immunol. 2007. 44: 2153-2164.
10. Clark, G. J., Fitzpatrick, S., Kuo, B., Modra, C., Jamriska, L. and Hart, D. N., CMRF-35A, CMRF-35H: potential new CD. J. Biol. Regul. Homeost. Agents 2002. 16: 233-235.
11. Clark, G. J., Cooper, B., Fitzpatrick, S., Green, B. J. and Hart, D. N., The gene encoding the immunoregulatory signaling molecule CMRF-35A localized to human chromosome 17 in close proximity to other members of the CMRF-35 family. Tissue Antigens 2001. 57: 415-423.
12. Clark, G. J., Ju, X., Azlan, M., Tate, C., Ding, Y. and Hart, D. N., The CD300 molecules regulate monocyte and dendritic cell functions. Immunobiology 2009. 214: 730-736.
13. Clark, G. J., Green, B. J. and Hart, D. N., The CMRF-35H gene structure predicts for an independently expressed member of an ITIM/ITAM pair of molecules localized to human chromosome 17. Tissue Antigens 2000. 55: 101-109.
14. Green, B. J., Clark, G. J. and Hart, D. N., The CMRF-35 mAb recognizes a second leukocyte membrane molecule with a domain similar to the poly Ig receptor. Int. Immunol. 1998. 10: 891-899.
15. Lankry, D., Simic, H., Klieger, Y., Levi-Schaffer, F., Jonjic, S. and Mandelboim, O., Expression and function of CD300 in NK cells. J. Immunol. 2010. 185: 2877-2886.
16. Nakahashi-Oda, C., Tahara-Hanaoka, S., Honda, S., Shibuya, K. and Shibuya, A., Identification of phosphatidylserine as a ligand for the CD300a immunoreceptor. Biochem. Biophys. Res. Commun. 2012. 417: 646-650.
17. Simhadri, V. R., Andersen, J. F., Calvo, E., Choi, S. C., Coligan, J. E. and Borrego, F., Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells. Blood 2012. 119: 2799-2809.
18. Vance, J. E. and Steenbergen, R., Metabolism and functions of phosphatidylserine. Prog. Lipid Res. 2005. 44: 207-234.
19. Bevers, E. M., Comfurius, P. and Zwaal, R. F., Changes in membrane phospholipid distribution during platelet activation. Biochim. Biophys. Acta 1983. 736: 57-66.
20. Zwaal, R. F., Comfurius, P. and Bevers, E. M., Lipid-protein interactions in blood coagulation. Biochim. Biophys. Acta 1998. 1376: 433-453.
21. Ravichandran, K. S., Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums. J. Exp. Med. 2010. 207:1807-1817.
22. Bratton, D. L. and Henson, P. M., Apoptotic cell recognition: will the real phosphatidylserine receptor(s) please stand up? Curr. Biol. 2008. 18: R76-R79.
23. Fadok, V. A., Voelker, D. R., Campbell, P. A., Cohen, J. J., Bratton, D. L. and Henson, P. M., Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 1992. 148: 2207-2216.
24. Bratton, D. L., Fadok, V. A., Richter, D. A., Kailey, J. M., Guthrie, L. A. and Henson, P. M., Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase. J. Biol. Chem. 1997. 272: 26159-26165.
25. Savill, J. and Fadok, V., Corpse clearance defines the meaning of cell death. Nature 2000. 407: 784-788.
26. DeKruyff, R. H., Bu, X., Ballesteros, A., Santiago, C., Chim, Y. L., Lee, H. H., Karisola, P., et al., T cell/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells. J. Immunol. 2010. 184: 1918-1930.
27. Santiago, C., Ballesteros, A., Martinez-Munoz, L., Mellado, M., Kaplan, G. G., Freeman, G. J. and Casasnovas, J. M., Structures of T cell immunoglobulin mucin protein 4 show a metal-Ion-dependent ligand binding site where phosphatidylserine binds. Immunity 2007. 27: 941-951.
28. Kobayashi, N., Karisola, P., Pena-Cruz, V., Dorfman, D. M., Jinushi, M., Umetsu, S. E., Butte, M. J. et al., TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 2007. 27: 927-940.
29. Miyanishi, M., Tada, K., Koike, M., Uchiyama, Y., Kitamura, T. and Nagata, S., Identification of Tim4 as a phosphatidylserine receptor. Nature 2007. 450: 435-439.
30. Park, D., Tosello-Trampont, A. C., Elliott, M. R., Lu, M., Haney, L. B., Ma, Z., Klibanov, A. L. et al., BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature 2007. 450: 430-434.
31. Park, S. Y., Jung, M. Y., Kim, H. J., Lee, S. J., Kim, S. Y., Lee, B. H., Kwon, T. H. et al., Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ. 2008. 15: 192-201.
32. Hanayama, R., Tanaka, M., Miwa, K., Shinohara, A., Iwamatsu, A. and Nagata, S., Identification of a factor that links apoptotic cells to phagocytes. Nature 2002. 417: 182-187.
33. Lemke, G. and Rothlin, C. V., Immunobiology of the TAM receptors. Nat. Rev. Immunol. 2008. 8: 327-336.
34. Anderson, H. A., Maylock, C. A., Williams, J. A., Paweletz, C. P., Shu, H. and Shacter, E., Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat. Immunol. 2003. 4: 87-91.
35. Zulueta, J. J., Yu, F. S., Hertig, I. A., Thannickal, V. J. and Hassoun, P. M., Release of hydrogen peroxide in response to hypoxia-reoxygenation: role of an NAD(P)H oxidase-like enzyme in endothelial cell plasma membrane. Am. J. Respir. Cell Mol. Biol. 1995. 12: 41-49.
36. Stafford, J. H. and Thorpe, P. E., Increased exposure of phosphatidylethanolamine on the surface of tumor vascular endothelium. Neoplasia 2011. 13: 299-308.
37. Woehlecke, H., Pohl, A., Alder-Baerens, N., Lage, H. and Herrmann, A., Enhanced exposure of phosphatidylserine in human gastric carcinoma cells overexpressing the half-size ABC transporter BCRP (ABCG2). Biochem. J. 2003. 376: 489-495.
38. Dong, H. P., Holth, A., Kleinberg, L., Ruud, M. G., Elstrand, M. B., Trope, C. G., Davidson, B. et al. Evaluation of cell surface expression of phosphatidylserine in ovarian carcinoma effusions using the annexin-V/7-AAD assay: clinical relevance and comparison with other apoptosis parameters. Am. J. Clin. Pathol. 2009. 132: 756-762.
39. Kirszberg, C., Lima, L. G., Da Silva de Oliveira, A., Pickering, W., Gray, E., Barrowcliffe, T. W., Rumjanek, V. M. et al., Simultaneous tissue factor expression and phosphatidylserine exposure account for the highly procoagulant pattern of melanoma cell lines. Melanoma Res. 2009. 19: 301-308.
40. Chuang, S. S., Kim, M. H., Johnson, L. A., Albertsson, P., Kitson, R. P., Nannmark, U., Goldfarb, R. H. et al., 2B4 stimulation of YT cells induces natural killer cell cytolytic function and invasiveness. Immunology 2000. 100: 378-383.
41. Speckman, R. A., Wright Daw, J. A., Helms, C., Duan, S., Cao, L., Taillon-Miller, P., Kwok, P. Y. et al., Novel immunoglobulin superfamily gene cluster, mapping to a region of human chromosome 17q25, linked to psoriasis susceptibility. Hum. Genet. 2003. 112: 34-41.
42. Clark, G. J., Ju, X., Tate, C. and Hart, D. N., The CD300 family of molecules are evolutionarily significant regulators of leukocyte functions. Trends Immunol. 2009. 30: 209-217.
43. Takatsu, H., Hase, K., Ohmae, M., Ohshima, S., Hashimoto, K., Taniura, N., Yamamoto, A. et al. CD300 antigen like family member G: a novel Ig receptor like protein exclusively expressed on capillary endothelium. Biochem. Biophys. Res. Commun. 2006. 348: 183-191.
44. Wu, L. N., Genge, B. R. and Wuthier, R. E., Analysis and molecular modeling of the formation, structure, and activity of the phosphatidylserine-calcium-phosphate complex associated with biomineralization. J. Biol. Chem. 2008. 283: 3827-3838.
45. Lentz, B. R., Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Prog. Lipid Res. 2003. 42: 423-438.
46. Ran, S., Downes, A. and Thorpe, P. E., Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res. 2002. 62: 6132-6140.
47. Riedl, S., Rinner, B., Asslaber, M., Schaider, H., Walzer, S., Novak, A., Lohner, K. et al., In search of a novel target - phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy. Biochim. Biophys. Acta 2011. 1808: 2638-2645.
48. Sprong, H., van der Sluijs, P. and van Meer, G., How proteins move lipids and lipids move proteins. Nat. Rev. Mol. Cell Biol. 2001. 2: 504-513.
49. Zwaal, R. F., Comfurius, P. and Bevers, E. M., Surface exposure of phosphatidylserine in pathological cells. Cell. Mol. Life Sci. 2005. 62: 971-988.
50. Head, D. J., Lee, Z. E., Poole, J. and Avent, N. D., Expression of phosphatidylserine (PS) on wild-type and Gerbich variant erythrocytes following glycophorin-C (GPC) ligation. Br. J. Haematol. 2005. 129: 130-137.
51. Yoneda, N., Tatsumi, E., Kawano, S., Teshigawara, K., Oka, T., Fukuda, M. and Yamaguchi, N., Detection of Epstein-Barr virus genome in natural-killer-like cell line, YT. Leukemia 1992. 6: 136-141.
52. Mandelboim, O., Reyburn, H. T., Vales-Gomez, M., Pazmany, L., Colonna, M., Borsellino, G. and Strominger, J. L., Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J. Exp. Med. 1996. 184: 913-922.